Selected research
Market Structure
Global Pets Parasiticide Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pets Parasiticide Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pets Parasiticide Medicines include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Vetoquinol, Virbac, Zoetis, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pets Parasiticide Medicines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pets Parasiticide Medicines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pets Parasiticide Medicines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pets Parasiticide Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.
Pets Parasiticide Medicines Segment by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Elanco
Vetoquinol
Virbac
Zoetis
Bayer
Merck
Pets Parasiticide Medicines Segment by Type
In Vitro Parasiticide Medicines
In Vivo Parasiticide Medicines
Pets Parasiticide Medicines Segment by Application
Cats
Equine
Dogs
Others
Pets Parasiticide Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Parasiticide Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets Parasiticide Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Parasiticide Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pets Parasiticide Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pets Parasiticide Medicines industry.
Chapter 3: Detailed analysis of Pets Parasiticide Medicines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pets Parasiticide Medicinesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Parasiticide Medicines
- In Vivo Parasiticide Medicines
Applications
- Cats
- Equine
- Dogs
- Others
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Elanco
- Vetoquinol
- Virbac
- Zoetis
- Bayer
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pets Parasiticide Medicines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 In Vitro Parasiticide Medicines
- 1.2.3 In Vivo Parasiticide Medicines
- 1.3 Market Analysis by Application
- 1.3.1 Global Pets Parasiticide Medicines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cats
- 1.3.3 Equine
- 1.3.4 Dogs
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Pets Parasiticide Medicines Growth Trends by Region
- 1.5.1 Global Pets Parasiticide Medicines Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pets Parasiticide Medicines Market Size by Region (2021-2026)
- 1.5.3 Pets Parasiticide Medicines Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pets Parasiticide Medicines Market Dynamics
- 2.1 Pets Parasiticide Medicines Industry Trends
- 2.2 Pets Parasiticide Medicines Industry Drivers
- 2.3 Pets Parasiticide Medicines Industry Opportunities and Challenges
- 2.4 Pets Parasiticide Medicines Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pets Parasiticide Medicines Revenue by Company (2021-2026)
- 3.2 Global Pets Parasiticide Medicines Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pets Parasiticide Medicines Key Company Head office and Area Served
- 3.4 Global Pets Parasiticide Medicines Company, Product Type & Application
- 3.5 Global Pets Parasiticide Medicines Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pets Parasiticide Medicines Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pets Parasiticide Medicines Players Market Share by Revenue in 2025
- 3.6.3 2025 Pets Parasiticide Medicines Tier 1, Tier 2, and Tier 3
4 Pets Parasiticide Medicines Market by Type
- 4.1 Global Pets Parasiticide Medicines Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pets Parasiticide Medicines Market Size by Type (2021-2032)
- 4.3 Global Pets Parasiticide Medicines Market Size Share by Type (2021-2032)
5 Pets Parasiticide Medicines Market by Application
- 5.1 Global Pets Parasiticide Medicines Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pets Parasiticide Medicines Market Size by Application (2021-2032)
- 5.3 Global Pets Parasiticide Medicines Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Bimeda Animal Health
- 6.1.1 Bimeda Animal Health Company Information
- 6.1.2 Bimeda Animal Health Business Overview
- 6.1.3 Bimeda Animal Health Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio
- 6.1.5 Bimeda Animal Health Recent Developments
- 6.2 Boehringer Ingelheim
- 6.2.1 Boehringer Ingelheim Company Information
- 6.2.2 Boehringer Ingelheim Business Overview
- 6.2.3 Boehringer Ingelheim Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio
- 6.2.5 Boehringer Ingelheim Recent Developments
- 6.3 Ceva Sante Animale
- 6.3.1 Ceva Sante Animale Company Information
- 6.3.2 Ceva Sante Animale Business Overview
- 6.3.3 Ceva Sante Animale Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio
- 6.3.5 Ceva Sante Animale Recent Developments
- 6.4 Elanco
- 6.4.1 Elanco Company Information
- 6.4.2 Elanco Business Overview
- 6.4.3 Elanco Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Elanco Pets Parasiticide Medicines Product Portfolio
- 6.4.5 Elanco Recent Developments
- 6.5 Vetoquinol
- 6.5.1 Vetoquinol Company Information
- 6.5.2 Vetoquinol Business Overview
- 6.5.3 Vetoquinol Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Vetoquinol Pets Parasiticide Medicines Product Portfolio
- 6.5.5 Vetoquinol Recent Developments
- 6.6 Virbac
- 6.6.1 Virbac Company Information
- 6.6.2 Virbac Business Overview
- 6.6.3 Virbac Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Virbac Pets Parasiticide Medicines Product Portfolio
- 6.6.5 Virbac Recent Developments
- 6.7 Zoetis
- 6.7.1 Zoetis Company Information
- 6.7.2 Zoetis Business Overview
- 6.7.3 Zoetis Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Zoetis Pets Parasiticide Medicines Product Portfolio
- 6.7.5 Zoetis Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Bayer Pets Parasiticide Medicines Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Merck Pets Parasiticide Medicines Product Portfolio
- 6.9.5 Merck Recent Developments
7 North America
- 7.1 North America Pets Parasiticide Medicines Market Size (2021-2032)
- 7.2 North America Pets Parasiticide Medicines Market Size by Type
- 7.2.1 North America Pets Parasiticide Medicines Market Size by Type (2021-2026)
- 7.2.2 North America Pets Parasiticide Medicines Market Size by Type (2027-2032)
- 7.2.3 North America Pets Parasiticide Medicines Market Share by Type (2021-2032)
- 7.3 North America Pets Parasiticide Medicines Market Size by Application
- 7.3.1 North America Pets Parasiticide Medicines Market Size by Application (2021-2026)
- 7.3.2 North America Pets Parasiticide Medicines Market Size by Application (2027-2032)
- 7.3.3 North America Pets Parasiticide Medicines Market Share by Application (2021-2032)
- 7.4 North America Pets Parasiticide Medicines Market Size by Country
- 7.4.1 North America Pets Parasiticide Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 7.4.3 North America Pets Parasiticide Medicines Market Size by Country (2027-2032)
- 7.4.4 North America Pets Parasiticide Medicines Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pets Parasiticide Medicines Market Size (2021-2032)
- 8.2 Europe Pets Parasiticide Medicines Market Size by Type
- 8.2.1 Europe Pets Parasiticide Medicines Market Size by Type (2021-2026)
- 8.2.2 Europe Pets Parasiticide Medicines Market Size by Type (2027-2032)
- 8.2.3 Europe Pets Parasiticide Medicines Market Share by Type (2021-2032)
- 8.3 Europe Pets Parasiticide Medicines Market Size by Application
- 8.3.1 Europe Pets Parasiticide Medicines Market Size by Application (2021-2026)
- 8.3.2 Europe Pets Parasiticide Medicines Market Size by Application (2027-2032)
- 8.3.3 Europe Pets Parasiticide Medicines Market Share by Application (2021-2032)
- 8.4 Europe Pets Parasiticide Medicines Market Size by Country
- 8.4.1 Europe Pets Parasiticide Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 8.4.3 Europe Pets Parasiticide Medicines Market Size by Country (2027-2032)
- 8.4.4 Europe Pets Parasiticide Medicines Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pets Parasiticide Medicines Market Size (2021-2032)
- 9.2 China Pets Parasiticide Medicines Market Size by Type
- 9.2.1 China Pets Parasiticide Medicines Market Size by Type (2021-2026)
- 9.2.2 China Pets Parasiticide Medicines Market Size by Type (2027-2032)
- 9.2.3 China Pets Parasiticide Medicines Market Share by Type (2021-2032)
- 9.3 China Pets Parasiticide Medicines Market Size by Application
- 9.3.1 China Pets Parasiticide Medicines Market Size by Application (2021-2026)
- 9.3.2 China Pets Parasiticide Medicines Market Size by Application (2027-2032)
- 9.3.3 China Pets Parasiticide Medicines Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pets Parasiticide Medicines Market Size (2021-2032)
- 10.2 Asia Pets Parasiticide Medicines Market Size by Type
- 10.2.1 Asia Pets Parasiticide Medicines Market Size by Type (2021-2026)
- 10.2.2 Asia Pets Parasiticide Medicines Market Size by Type (2027-2032)
- 10.2.3 Asia Pets Parasiticide Medicines Market Share by Type (2021-2032)
- 10.3 Asia Pets Parasiticide Medicines Market Size by Application
- 10.3.1 Asia Pets Parasiticide Medicines Market Size by Application (2021-2026)
- 10.3.2 Asia Pets Parasiticide Medicines Market Size by Application (2027-2032)
- 10.3.3 Asia Pets Parasiticide Medicines Market Share by Application (2021-2032)
- 10.4 Asia Pets Parasiticide Medicines Market Size by Country
- 10.4.1 Asia Pets Parasiticide Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 10.4.3 Asia Pets Parasiticide Medicines Market Size by Country (2027-2032)
- 10.4.4 Asia Pets Parasiticide Medicines Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pets Parasiticide Medicines Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Type
- 11.2.1 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pets Parasiticide Medicines Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Application
- 11.3.1 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pets Parasiticide Medicines Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Country
- 11.4.1 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pets Parasiticide Medicines Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pets Parasiticide Medicines Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst